Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis

Published:2017-09 Issue: Volume:380 Page:256-261
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Yang Ting-ting,Wang Li,Deng Xiao-yang,Yu Gang

Funder

National Science Foundation of Chongqing Science and Technology Commission

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference20 articles.

1. Management of fatigue in patients with multiple sclerosis;Zifko;Drugs,2004

2. The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis;Geisler;Arch. Neurol.,1996

3. Fatigue therapy in multiple sclerosis results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo;Krupp;Neurology,1995

4. A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. The Canadian MS Research Group;The Canadian MS Research Group;Can. J. Neurol. Sci.,1987

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fatigue in multiple sclerosis: can we measure it and can we treat it?;Journal of Neurology;2024-07-05

2. The use of modafinil for the treatment of fatigue in multiple sclerosis: A systematic review and meta‐analysis of controlled clinical trials;Brain and Behavior;2024-07

3. Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review;Frontiers in Immunology;2024-04-05

4. A randomized open-label clinical trial on the effect of Amantadine on post Covid 19 fatigue;Scientific Reports;2024-01-16

5. Overview of the Current Pathophysiology of Fatigue in Multiple Sclerosis, Its Diagnosis and Treatment Options – Review Article;Neuropsychiatric Disease and Treatment;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3